Suchergebnisse - "Bowlus, Christopher L"

PubPharm (282)

1

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

enthalten in: The New England journal of medicine | 2024

von Kowdley, K. | Bowlus, C. | Levy, C. | +102

2

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

enthalten in: The New England journal of medicine | 2024

von Hirschfield, G. | Bowlus, C. | Mayo, M. | +94

3

Per-oral cholangioscopy in patients with primary sclerosing cholangitis : a 12-month follow-up study

enthalten in: Endoscopy international open | 2024

von Mohamed, R. | Tejaswi, S. | Aabakken, L. | +10

4

Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary Cholangitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Zheng, L. | Tian, S. | Yang, C. | +15

5

African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis

enthalten in: Hepatology communications | 2024

von Yazdanfar, M. | Zepeda, J. | Dean, R. | +21

6

Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitis

enthalten in: Abdominal radiology (New York) | 2024

von Grave, E. | Loehfelm, T. | Corwin, M. | +5

7

Open-label, clinical trial extension : Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

8

Optimizing treatment of primary biliary cholangitis : Is good, good enough?

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Bowlus, C. | Levy, C.

9

Editorial : The evolving paradigms and treatments for primary biliary cholangitis-Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C.

10

Open‐label, clinical trial extension : Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Mayo, M. | Vierling, J. | Bowlus, C. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]